Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Saliva substitute refers to a range of over-the-counter artificial preparations designed to temporarily relieve symptoms of dry mouth (xerostomia) by mimicking the lubricating and protective properties of natural saliva. These substitutes typically contain water, cellulose derivatives or thickeners (e.g., carboxymethylcellulose, sorbitol, glycerol), sometimes with added electrolytes, flavoring agents, or pH buffers. Unlike biological targets, saliva substitute is a symptomatic replacement that does not modulate endogenous pathways or molecular targets; it acts locally by wetting and protecting the oral mucosa. Artificial saliva is offered in forms such as sprays, lozenges, gels, rinses, and mouthwashes. There is no universal equivalent to the complex mixture of proteins, mucins, and antimicrobial peptides found in natural saliva. These products are mainly intended for patients who cannot use salivary stimulants or whose salivary gland function is irreversibly impaired.
Forms a protective lubricating film over oral tissues to temporarily replace or supplement diminished saliva
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Saliva substitute.